Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Obstetrics

Initial Diagnosis of Achondrogenesis: A Guide for Parents

At a Glance

Achondrogenesis is a rare, severe genetic disorder that prevents fetal bones and cartilage from developing properly. It is a fatal condition because the baby's lungs cannot fully develop. Care focuses on protecting the mother's health and providing perinatal palliative care for the baby's comfort.

Receiving a diagnosis of achondrogenesis is devastating. This guide is here to provide clarity on the biological facts of the condition and to help you navigate the difficult path ahead with information and compassion.

Understanding Achondrogenesis

Achondrogenesis is a group of rare, severe skeletal disorders that affect how bones and cartilage develop [1]. It is an exceptionally rare condition, occurring in approximately one in every 40,000 to 60,000 births [1].

The hallmark of the condition is delayed ossification, which means the baby’s bones do not harden with calcium and minerals as they normally should during development [2][3]. This leads to extremely short limbs (referred to medically as tetramicromelia), a very small chest, and a skull that is often severely under-ossified or soft [1][4].

Why This Happened

Achondrogenesis is purely a genetic event. It occurs when specific genes that provide the body’s instructions for building bone and cartilage contain errors. There are three main types, each caused by different genetic mutations:

  • Type IA (Houston-Harris type): Caused by mutations in the TRIP11 gene [5][6].
  • Type IB (Parenti-Fraccaro type): Caused by mutations in the SLC26A2 gene [7][1].
  • Type II (Langer-Saldino type): Caused by a mutation in the COL2A1 gene [8][9].

In most cases of Types IA and IB, both parents silently carry a recessive gene for the condition [5]. In Type II, it is usually a “de novo” or completely new mutation that occurs entirely by chance at the moment of conception [3][9].

The Medical Reality

It is deeply painful to hear, but achondrogenesis is universally classified as a lethal skeletal dysplasia, meaning it is not compatible with life outside the womb [10][11].

The primary reason for this is a complication called pulmonary hypoplasia, which means the baby’s lungs are severely underdeveloped [12]. Because the baby’s rib cage is too small and fragile to allow the lungs to grow to a functional size or to support the physical mechanics of breathing, babies with this condition are either stillborn or pass away peacefully shortly after birth due to respiratory insufficiency [12][2].

Navigating Care for the Mother and Family

While the focus naturally turns toward the baby, the mother’s physical health and the family’s emotional well-being are the primary medical priorities moving forward.

  • Protecting the Mother: This condition is frequently associated with maternal complications such as polyhydramnios (a severe buildup of excess amniotic fluid) and fetal swelling [12][13]. Your medical team will monitor you closely to prevent dangerous complications.
  • Birth Planning: Knowing the outcome in advance allows you to make decisions about the birth that honor your family’s wishes [12]. You will be offered perinatal palliative care, which focuses entirely on keeping the baby warm and comfortable, and allowing for peaceful bonding time rather than performing painful, futile medical interventions [12][14].
  • Confirming the Diagnosis: While ultrasound and fetal MRI provide strong clues, doctors will recommend genetic testing (such as a microarray or whole-exome sequencing) to confirm the exact type of achondrogenesis [15][2]. This information is not to change the outcome for your current baby, but to help you understand the risks for any future pregnancies you may plan [14][16].

You are facing one of the most difficult challenges a parent can endure. You do not have to make every decision today. Lean on your medical team to support you, ensure the mother’s physical safety, and help you prepare to maximize the precious time you have with your child.

Common questions in this guide

What causes achondrogenesis?
Achondrogenesis is a genetic condition caused by errors in the genes that instruct the body to build bone and cartilage. Types IA and IB are usually inherited when both parents silently carry a recessive gene, while Type II often happens as a completely new mutation by chance.
Is achondrogenesis survivable?
Sadly, achondrogenesis is considered a lethal condition. Because the baby's rib cage is too small to allow the lungs to develop properly, babies with this condition are either stillborn or pass away peacefully shortly after birth.
What does palliative birth planning involve for achondrogenesis?
Perinatal palliative care focuses entirely on the baby's comfort and giving your family peaceful bonding time. It avoids painful and futile medical interventions, prioritizing keeping the baby warm and comfortable after birth.
What are the health risks for the mother during an achondrogenesis pregnancy?
Mothers carrying a baby with achondrogenesis are at risk for complications like polyhydramnios, which is a severe buildup of excess amniotic fluid. Your medical team will monitor you closely to protect your health and prevent dangerous complications.
Why is genetic testing recommended after an achondrogenesis diagnosis?
Genetic testing helps doctors confirm the exact type of achondrogenesis by identifying the specific gene mutation. This information is crucial for understanding the exact genetic risks for any future pregnancies you may plan.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific type of achondrogenesis (Type IA, IB, or II) is suspected based on the ultrasound or MRI findings?
  2. 2.Has genetic testing (like whole-exome sequencing or a skeletal dysplasia panel) been recommended to confirm the exact mutation?
  3. 3.What are our options for birth planning that prioritize our child's comfort and maximize our time together?
  4. 4.Are there specific maternal health risks, such as polyhydramnios (excess amniotic fluid), that we should be monitoring for right now?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Achondrogenesis Type 2 in a Newborn with a Novel Mutation on the COL2A1 Gene.

    Dogan P, Varal IG, Gorukmez O, et al.

    Balkan journal of medical genetics : BJMG 2019; (22(1)):89-94 doi:10.2478/bjmg-2019-0001.

    PMID: 31523626
  2. 2

    Diagnosis of Prenatal-Onset Achondrogenesis Type II by a Multidisciplinary Assessment: A Retrospective Study of 2 Cases.

    Wang W, Wu Q, Sun L, et al.

    Case reports in obstetrics and gynecology 2019; (2019()):7981767 doi:10.1155/2019/7981767.

    PMID: 31392067
  3. 3

    Skeletal Dysplasia: A Case Report.

    Gică N, Mîrza G, Gică C, et al.

    Diagnostics (Basel, Switzerland) 2023; (13(18)) doi:10.3390/diagnostics13182905.

    PMID: 37761271
  4. 4

    Lethal and life-limiting skeletal dysplasias: Selected prenatal issues.

    Stembalska A, Dudarewicz L, Śmigiel R

    Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2021; (30(6)):641-647 doi:10.17219/acem/134166.

    PMID: 34019743
  5. 5

    Achondrogenesis type 1A: clinical, histologic, molecular, and prenatal ultrasound diagnosis.

    Vanegas S, Sua LF, López-Tenorio J, et al.

    The application of clinical genetics 2018; (11()):69-73 doi:10.2147/TACG.S157235.

    PMID: 29872333
  6. 6

    The skeletal phenotype of achondrogenesis type 1A is caused exclusively by cartilage defects.

    Bird IM, Kim SH, Schweppe DK, et al.

    Development (Cambridge, England) 2018; (145(1)) doi:10.1242/dev.156588.

    PMID: 29180569
  7. 7

    Suppressing UPR-dependent overactivation of FGFR3 signaling ameliorates SLC26A2-deficient chondrodysplasias.

    Zheng C, Lin X, Xu X, et al.

    EBioMedicine 2019; (40()):695-709 doi:10.1016/j.ebiom.2019.01.010.

    PMID: 30685387
  8. 8

    Novel missense COL2A1 variant in a fetus with achondrogenesis type II.

    Kobayashi Y, Ito Y, Taniguchi K, et al.

    Human genome variation 2022; (9(1)):40 doi:10.1038/s41439-022-00218-5.

    PMID: 36376277
  9. 9

    A Novel Splicing Variant of COL2A1 in a Fetus with Achondrogenesis Type II: Interpretation of Pathogenicity of In-Frame Deletions.

    Bruni V, Spoleti CB, La Barbera A, et al.

    Genes 2021; (12(9)) doi:10.3390/genes12091395.

    PMID: 34573377
  10. 10

    Further evidence for attenuated phenotype with variants in the BMPER gene causing DSD: Case report and literature review.

    Batey N, Spiller M, Balasubramanian M

    European journal of medical genetics 2022; (65(4)):104470 doi:10.1016/j.ejmg.2022.104470.

    PMID: 35240322
  11. 11

    Pathogenicity effects of a COL2A1 missense mutation (c.1594G>C) in cartilage development.

    Zhou J, Yuan T

    Translational pediatrics 2025; (14(7)):1511-1519 doi:10.21037/tp-2025-79.

    PMID: 40800180
  12. 12

    Using MRI-derived observed-to-expected total fetal lung volume to predict lethality in fetal skeletal dysplasia.

    Mehollin-Ray AR, Stover S, Cassady CI, et al.

    Pediatric radiology 2024; (54(1)):43-48 doi:10.1007/s00247-023-05825-0.

    PMID: 38052986
  13. 13

    Two unrelated pedigrees with achondrogenesis type 1b carrying a Japan-specific pathogenic variant in SLC26A2.

    Sato T, Kojima T, Samura O, et al.

    American journal of medical genetics. Part A 2020; (182(4)):735-739 doi:10.1002/ajmg.a.61469.

    PMID: 31880411
  14. 14

    Antenatal Phenotype of Desbuquois Dysplasia.

    Biji IK, Mahay SB, Saxena R, et al.

    Indian journal of pediatrics 2023; (90(1)):83-86 doi:10.1007/s12098-022-04386-8.

    PMID: 36331722
  15. 15

    Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasia.

    Scocchia A, Kangas-Kontio T, Irving M, et al.

    Orphanet journal of rare diseases 2021; (16(1)):412 doi:10.1186/s13023-021-02025-7.

    PMID: 34627339
  16. 16

    Prenatal diagnosis of fetal skeletal dysplasia using targeted next-generation sequencing: an analysis of 30 cases.

    Liu Y, Wang L, Yang YK, et al.

    Diagnostic pathology 2019; (14(1)):76 doi:10.1186/s13000-019-0853-x.

    PMID: 31299979

This page provides educational information about an achondrogenesis diagnosis for informational purposes only. Please consult closely with your maternal-fetal medicine specialist and genetic counselor regarding your specific pregnancy and care options.

Get notified when new evidence is published on Achondrogenesis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.